Brown Gemma bought BRNS
January 2, 2024 · Form 4 insider transaction
Brown Gemma bought 193,000 shares of Barinthus Biotherapeutics PLC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
193,000
Price
$0.00
Total value
N/A
InsiderBrown Gemma
Role—
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after193,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.